The role of arginine vasopressin (AVP) in malignant renal hypertension was investigated using the homozygous Brattieboro (vasopressin-deficient) rat. Brattieboro rats with complete aortic-iigature between the renal arteries developed malignant hypertension with the same frequency and severity as normal Long-Evans rats subjected to the same procedure. The Long-Evaris hypertensive rats had significantly elevated plasma AVP levels. Plasma renin activity and plasma angiotensin II levels were significantly elevated in both Brattieboro and Long-Evans rats with malignant hypertension and the levels reached were equivalent in both groups. Thus, the renin-angiotensin system did not compensate for the lack of AVP in malignant hypertensive Brattieboro rats. Specific vascular lesions of fibrinoid necrosis were observed in a high percentage of rats with malignant hypertension, in both the Brattieboro and Long-Evans strains. We conclude that AVP does not play a primary role in the pathogenesis of malignant renal hypertension and, in particular, in the development of the vascular lesions of fibrinoid necrosis.
|Number of pages||7|
|Journal||Journal of Hypertension|
|Publication status||Published - 1983|
- Arginine vasopressin
- Fibrinoid necrosis
- Malignant renal hypertension